Long non‐coding RNA activated by DNA damage (lnc‐NORAD) modulates inflammation, lipid level, and atherosclerosis in various cardiovascular diseases. This study intended to investigate the dysregulated expression of lnc‐NORAD, and its… Click to show full abstract
Long non‐coding RNA activated by DNA damage (lnc‐NORAD) modulates inflammation, lipid level, and atherosclerosis in various cardiovascular diseases. This study intended to investigate the dysregulated expression of lnc‐NORAD, and its linkage with clinical characteristics, inflammatory cytokines, and accumulating major adverse cardiovascular events (MACE) in coronary heart disease (CHD) patients.
               
Click one of the above tabs to view related content.